Welcome to the Office of Cancer Survivorship Program, DCCPS
The NCI Office of Cancer Survivorship (OCS) works to enhance the quality and length of survival of all persons diagnosed with cancer and to prevent, minimize, or manage adverse effects of cancer and its treatment.
OCS Director's Series presents Sexual Concerns of Cancer Survivors: Are We Closer to Addressing this Unmet Need?
June 2023 – Register now for this upcoming OCS Director’s Series webinar. On June 13, 2023, from 2-3 p.m. ET, Dr. Jennifer Reese will present Sexual Concerns of Cancer Survivors: Are We Closer to Addressing this Unmet Need?
OCS Director's Series presents Optimizing Care Delivery for Cancer Survivors: Engaged, Pragmatic, Multi-team & Multi-level
September 2023 – Join the NCI Office of Cancer Survivorship for this upcoming OCS Director’s Series webinar. On September 19, 2023, from 2-3 p.m. ET, Dr. Simon Craddock Lee will present Optimizing Care Delivery for Cancer Survivors: Engaged, Pragmatic, Multi-team & Multi-level. Register now.
Lancet commentary – Childhood Cancer Survivors: Healthy Behaviours and Late Mortality
In this recent commentary in The Lancet, OCS Director Dr. Emily Tonorezos discusses the association between decreased health-related mortality and healthy behaviors in childhood cancer survivors.
Financial navigation can reduce the financial toxicity of cancer care. Read more in this new NCI Cancer Currents Blog.
About The Office of Cancer Survivorship
An individual is considered a cancer survivor from the time of diagnosis, through the balance of life. There are many types of survivors, including those living with cancer and those free of cancer. This term is meant to capture a population of those with a history of cancer rather than to provide a label that may or may not resonate with individuals.
OCS works to promote a better understanding of unique needs of the growing population of cancer survivors, and to enhance our ability to address them.
Featured Graph and Statistic
Individuals Living with Metastatic Cancer
Researchers at the National Cancer Institute have estimated that 623,405 people in the United States were living with metastatic breast, prostate, lung, colorectal, or bladder cancer or metastatic melanoma as of 2018, and that number is expected to increase to 693,452 by the year 2025.
Cancer Survivor Statistics
It is estimated that there are 18.1 million cancer survivors in the United States. This represents approximately 5.4% of the population.